192 related articles for article (PubMed ID: 30742098)
1. Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
Torres-Hernandez A; Wang W; Nikiforov Y; Tejada K; Torres L; Kalabin A; Wu Y; Haq MIU; Khan MY; Zhao Z; Su W; Camargo J; Hundeyin M; Diskin B; Adam S; Rossi JAK; Kurz E; Aykut B; Shadaloey SAA; Leinwand J; Miller G
Oncogene; 2019 Jun; 38(23):4512-4526. PubMed ID: 30742098
[TBL] [Abstract][Full Text] [Related]
2. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.
Luci C; Vieira E; Bourinet M; Rousseau D; Bonnafous S; Patouraux S; Lefevre L; Larbret F; Prod'homme V; Iannelli A; Tran A; Anty R; Bailly-Maitre B; Deckert M; Gual P
Cell Mol Gastroenterol Hepatol; 2022; 13(1):173-191. PubMed ID: 34411785
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Qu C; Zheng D; Li S; Liu Y; Lidofsky A; Holmes JA; Chen J; He L; Wei L; Liao Y; Yuan H; Jin Q; Lin Z; Hu Q; Jiang Y; Tu M; Chen X; Li W; Lin W; Fuchs BC; Chung RT; Hong J
Hepatology; 2018 Sep; 68(3):1125-1139. PubMed ID: 29537660
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
5. Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways.
Seifert L; Deutsch M; Alothman S; Alqunaibit D; Werba G; Pansari M; Pergamo M; Ochi A; Torres-Hernandez A; Levie E; Tippens D; Greco SH; Tiwari S; Ly NNG; Eisenthal A; van Heerden E; Avanzi A; Barilla R; Zambirinis CP; Rendon M; Daley D; Pachter HL; Hajdu C; Miller G
Cell Rep; 2015 Dec; 13(9):1909-1921. PubMed ID: 26655905
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
7. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
8. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
9. Deregulated neddylation in liver fibrosis.
Zubiete-Franco I; Fernández-Tussy P; Barbier-Torres L; Simon J; Fernández-Ramos D; Lopitz-Otsoa F; Gutiérrez-de Juan V; de Davalillo SL; Duce AM; Iruzubieta P; Taibo D; Crespo J; Caballeria J; Villa E; Aurrekoetxea I; Aspichueta P; Varela-Rey M; Lu SC; Mato JM; Beraza N; Delgado TC; Martínez-Chantar ML
Hepatology; 2017 Feb; 65(2):694-709. PubMed ID: 28035772
[TBL] [Abstract][Full Text] [Related]
10. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence.
Jin H; Lian N; Zhang F; Chen L; Chen Q; Lu C; Bian M; Shao J; Wu L; Zheng S
Cell Death Dis; 2016 Apr; 7(4):e2189. PubMed ID: 27077805
[TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase (SYK) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction.
Xie G; Liu W; Lian Z; Xie D; Yuan G; Ye J; Lin Z; Wang W; Zeng J; Shen H; Wang X; Feng H; Cong W; Yao G
Biochem Pharmacol; 2021 Jun; 188():114579. PubMed ID: 33895161
[TBL] [Abstract][Full Text] [Related]
13. Role of spleen tyrosine kinase in liver diseases.
Kurniawan DW; Storm G; Prakash J; Bansal R
World J Gastroenterol; 2020 Mar; 26(10):1005-1019. PubMed ID: 32205992
[TBL] [Abstract][Full Text] [Related]
14. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells.
Ceni E; Mello T; Polvani S; Vasseur-Cognet M; Tarocchi M; Tempesti S; Cavalieri D; Beltrame L; Marroncini G; Pinzani M; Milani S; Galli A
J Hepatol; 2017 Apr; 66(4):754-764. PubMed ID: 27866920
[TBL] [Abstract][Full Text] [Related]
15. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
16. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
[TBL] [Abstract][Full Text] [Related]
17. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
18. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis.
Patel D; Gaikwad S; Challagundla N; Nivsarkar M; Agrawal-Rajput R
Int Immunopharmacol; 2018 Jan; 54():375-384. PubMed ID: 29202301
[TBL] [Abstract][Full Text] [Related]
20. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
